Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.
about
Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 DiabetesLifestyle therapy for the treatment of youth with type 2 diabetesβ-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.Drugs for the treatment of pediatric type 2 diabetes mellitus and related co-morbidities.Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life spanPathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry.β-cell failure in type 2 diabetes: postulated mechanisms and prospects for prevention and treatment.Estimation of insulin sensitivity in children: methods, measures and controversiesPrognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studiesRetrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome.Nephropathy in youth and young adults with type 2 diabetesDiabetic kidney disease in children and adolescents.We can change the natural history of type 2 diabetes.β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes.Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trialComplication characteristics between young-onset type 2 versus type 1 diabetes in a UK populationEfficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trial.Parental Characteristics Associated With Outcomes in Youth With Type 2 Diabetes: Results From the TODAY Clinical Trial.Importance of Beta Cell Function for the Treatment of Type 2 DiabetesPioglitazone is an effective treatment for patients with post-stroke depression combined with type 2 diabetes mellitusSignificant retinopathy in young-onset type 2 vs. type 1 diabetes: a clinical observation.In Nonobese Girls, Waist Circumference as a Predictor of Insulin Resistance Is Comparable to MRI Fat Measures and Superior to BMI.HbA1c After a Short Period of Monotherapy With Metformin Identifies Durable Glycemic Control Among Adolescents With Type 2 Diabetes.Relationship Between Parental Diabetes and Presentation of Metabolic and Glycemic Function in Youth With Type 2 Diabetes: Baseline Findings From the TODAY Trial.The TODAY study: an NIH perspective on its implications for research.Safety and tolerability of the treatment of youth-onset type 2 diabetes: the TODAY experience.Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children.Bariatric Surgery: A Potential Treatment for Type 2 Diabetes in Youth.Pharmacological interventions for preventing or delaying onset of type 2 diabetes mellitus.Morbidity and mortality in young-onset type 2 diabetes in comparison to type 1 diabetes: where are we now?Clinical trials in youth-onset type 2 diabetes: needs, barriers, and options.The changing face of diabetes in youth: lessons learned from studies of type 2 diabetes.Youth-Onset Type 2 Diabetes Consensus Report: Current Status, Challenges, and Priorities.Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience.C-peptide levels in pediatric type 2 diabetes in the Pediatric Diabetes Consortium T2D Clinic Registry.Cardiovascular complications of type 2 diabetes in youth.Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes.Comment on: TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care 2013;36:1749-1757.“TODAY” reflects on the changing “faces” of type 2 diabetes.
P2860
Q26747696-456A8F47-8B80-4A81-AE43-A3DAECB78E62Q26995151-78AD8572-A7F3-467F-87A5-3064A8B233EEQ27692665-CF94056C-91E1-4AC2-980C-26BB0473FE2AQ30241716-9587008E-185E-4E94-BBB0-AE75F288BACAQ30572405-3FEFBC6C-33CE-4F71-B41D-B26EAFB74523Q30597265-4B299065-F97A-430D-A0E4-804D16CBB1A0Q31057431-800FADCC-CB63-485D-8382-E823677EDD4AQ33570085-BCA88F42-00E7-4070-9566-2DB5B4A85993Q33670227-2E9DD46F-3915-4AEF-BFA6-1C1BF3C53E05Q33688699-267F5708-1064-45D5-AD9F-4F33162DF815Q33749648-4B776DFE-2E06-4F0B-9FAA-FB306DB8CE99Q33903763-C59AE006-30F0-404D-A984-D9E25B837384Q34214578-129D2E63-424C-49AD-A09F-7629CC9A8CF7Q34219402-1ECB041A-061F-40A0-B838-A1B22B869F0CQ34393402-F6A6269A-4044-4B1B-88E3-E699B16DAA60Q34586302-D7DFB356-34B8-4AC1-9EAB-A9768C0B40ABQ35107446-B6A9D52C-C0D8-4836-BDD1-C4605BBA6458Q35225372-BE60DAB6-CBD1-422D-B07A-7C510C569127Q35531924-E3C8F876-6242-4EC4-BE66-8F48EFF2DFE0Q35667116-4C0B8076-38FA-450D-924C-6D7561C4A45AQ35942767-5A9D3F01-21BA-4406-AA47-93114DFDFCB2Q35974230-805EA88B-6C5A-41A7-9643-0C4A97B890A8Q36277690-931D9167-397D-45E7-B5F9-85DC67B178E5Q36311680-734991BE-4AC9-4820-BF8F-1AD4504A9268Q36392563-27A756E8-D384-4015-AE84-3C52ADE88B11Q36868118-1B58AADA-8F23-4E57-AA63-63265D0F97B5Q36868257-2D7A5718-BC73-43C5-BEEC-53D01E7FD0D1Q36963380-A8B1FD4B-4DB6-473B-831D-A7497A69F42CQ37652822-285871FF-1EC9-4176-9376-23F2BFCE60BBQ38259933-A7A9D88F-1BAC-4AD8-A4F8-C4FB5540FA11Q38268270-0B8A00BC-DA4B-4F2C-A02D-52CC94018A44Q38380568-C8D1E21B-26E1-4459-B369-F1AF1F363683Q38602464-A37074FE-F2CC-49C9-B65D-7DB820633116Q38835019-2F2D7279-9546-462A-B2A8-985871C1BC92Q40628070-DF4EFBF8-B98F-4220-85C8-21533C966C73Q40976863-278EB750-00B9-48D4-900A-9B4DF238FE3FQ41514778-88D7FF16-28FD-469B-9D87-78EDE89F6ABFQ42718202-9D42C744-2C0E-4EDB-82E1-765524B063B6Q42874291-4E62C0DA-F901-4027-8E3A-E4E92E3B1827Q43153423-3CCED2C1-EE0C-4D13-8223-CD020A02E95D
P2860
Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effects of metformin, metformi ...... and β-cell function in TODAY.
@en
type
label
Effects of metformin, metformi ...... and β-cell function in TODAY.
@en
prefLabel
Effects of metformin, metformi ...... and β-cell function in TODAY.
@en
P2860
P356
P1433
P1476
Effects of metformin, metformi ...... and β-cell function in TODAY.
@en
P2093
TODAY Study Group
P2860
P304
P356
10.2337/DC12-2393
P407
P577
2013-06-01T00:00:00Z